Uropathogenic Escherichia coli as a model of host–parasite interaction
Introduction
Urinary tract infections (UTIs) provide an excellent model to study how the host recognises and deals with mucosal pathogens [1, 2, 3]. The infecting strain encounters a microbially naïve mucosal environment where it may cause acute, potentially life-threatening infections. Chronic sequels are prevalent, and there is a link between acute infection and chronicity [4, 5]. The mechanisms underlying commensalism can also be studied in the urinary tract, because asymptomatic bacteriuria (ABU) occurs in at least 1% of the population, who can carry >105 cfu/ml of Escherichia coli in their urine for months or years with no or few symptoms [6, 7]. Studies in the UTI model have identified molecular mechanisms that initiate tissue attack by mucosal pathogens and that trigger the innate host response [8•]. On the basis of these mechanisms the genetics of disease susceptibility are beginning to be understood [9, 10].
The severity of UTI reflects the virulence of the infecting strain. In the 1940s, hemolysin was identified as a characteristic of E. coli that cause extra-intestinal infections [11]. Uropathogenic E. coli (UPEC) strains were later shown to belong to a restricted set of serotypes or ‘clones’ [12], and strains causing acute pyelonephritis and ABU strains were found to differ in surface-antigen repertoire [7]. In the 1970s, this information was extended to involve attachment to the urinary tract mucosa [13]. High tissue-attachment was shown to characterise the most virulent strains but not the asymptomatic carrier strains. Attachment was thus proposed as the first step in the pathogenesis of UTI, and the epithelial cell was recognised as the first sensor of tissue attack [14, 15, 16]. Since then, the molecular basis of virulence has been extensively studied, and several essential virulence factors have been identified [17]. The virulence genes are encoded on pathogenicity islands, and their expression, regulation and evolution have been elegantly characterised [18, 19, 20]. Recent studies have suggested that ABU strains might be attenuated pathogens, carrying deletions in the virulence genes involved in attachment and tissue attack (Figure 1) [21].
The virulence factors enable UPEC to trigger epithelial cell responses leading to inflammation, cell detachment and apoptosis, or invasion and bacteremia [14, 15, 22, 23, 24, 25, 26, 27, 28•]. The tissue response is lethal for the organism, however, and it is unlikely that invasion offers a significant advantage that would drive the evolution of the virulent phenotype. It is more likely that the adaptation of uropathogenic clones occurs mainly in the large intestine, and that virulence is ‘co-incidental’ [29]. For example, the mucosal receptors for P-fimbriated uropathogens are expressed in both the intestinal and urinary tracts, but ligand-binding has different consequences at the two sites. In the urinary tract, attaching P-fimbriated strains evokes the host response, and P-fimbrial signalling through TLR4 leads either, to elimination of the bacteria or to disease [30]. In the large intestine, however, P-fimbriae promote bacterial persistence, but there is no evidence of inflammation. ABU resembles the intestinal carrier state as the bacteria persist without provoking a host response. Recent studies have suggested that ABU strains carry virulence genes, but do not express them. ABU might thus represent a successful adaptation, because the bacteria can persist without competition in a niche with a rich nutrient source, often for several years. In this case, the host might produce signals that attenuate bacterial virulence.
Susceptibility to UTI varies greatly among the population, as does the severity of disease among susceptible individuals [31]. Studies in pyelonephritis-prone children have identified ‘high responders’ which exhibit abnormalities that exaggerate the damaging rather than protective aspects of innate immunity [3, 32]. Experimental infections in different mutant mice have identified a single gene defect that causes the high responder phenotype [5]. Neutrophils are crucial effectors of host defence in the urinary tract, and neutrophil dysfunctions — owing to defective IL-8 receptor expression — cause acute pyelonephritis and renal scarring [10]. In ‘low responders’, however, bacteriuria establishes without evoking a response, showing that suppression of inflammatory signals may be protective even though the infection remains. Furthermore, experimental infections have identified genetic control mechanisms that decide if the host will remain asymptomatic or develop disease. Mice carrying a mutation in the signalling domain of Toll-like receptor 4 (TLR4) develop an asymptomatic carrier state resembling human ABU infection [33, 34, 35].
This review focuses on these two steps in disease pathogenesis and their consequences for human disease.
Section snippets
Step 1: mechanism of pathogen recognition and host response induction
Pathogen recognition by the mucosa is guided by molecular specificity. Attachment is an essential first step that promotes bacterial persistence and activates the host defence signalling pathways (Figure 2; Step 1) [13, 14, 36•]. The commensals mostly lack the virulence-associated adhesive ligands and fail to bind to signalling receptors in the mucosa. The situation might be different in the gut, where pathogens have been proposed to actively inhibit the epithelial response by disrupting
Step 2: neutrophil defects and genetics of disease susceptibility
The antibacterial defence of the urinary tract relies almost entirely on innate immunity. Following intra-vesical inoculation, bacteriuria is cleared within hours or days, and neutrophils are the crucial effector cells. The infected uroepithelial cells secrete chemotactic substances, including chemokines [15, 16, 56]. A chemotactic gradient is created and, in response to the gradient, neutrophils leave the bloodstream, migrate through the tissues and cross the epithelial barrier into the lumen.
Genetics of human disease susceptibility
The results described above suggest at least three ways in which genetic variation may influence human disease susceptibility.
Conclusions
The urinary tract mucosa relies on innate immunity for its antimicrobial defence. Specific host–microbe molecular interactions between are required to activate mucosal inflammation, and virulence factors determine which signal transduction pathways are engaged. Uropathogenic E. coli use their virulence factors to break the inertia of the mucosal barrier. Bacterial adherence is crucial and pathogen recognition by the host is controlled by fimbrial adhesins and cell receptors. Pathogen binding
References and recommended reading
Papers of particular interest, published within the annual period of review, have been highlighted as:
• of special interest
•• of outstanding interest
Acknowledgements
This work was supported by grants from the Swedish Medical Research Council (Grants No. 07934, 14577, 14578), The Royal Physiographic Society, The Medical Faculty, Lund University, The Wallenberg and Lundberg Foundations. Catharina Svanborg was a recipient of the unrestricted grant award from Bristol-Myer Squibb.
References (73)
Urinary Tract Infections. Detection, Prevention and Management
(1997)- et al.
The ‘innate’ host response protects and damages the infected urinary tract
Ann Med
(2001) - et al.
Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection
J Leukoc Biol
(2001) - et al.
Experimental pyelonephritis in the monkey. II. The prognostic value of radionuclide evaluation of the urinary tract
Invest Urol
(1975) - et al.
Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis
J Infect Dis
(2000) - et al.
Urinary tract infection in school children: an epidemiologic, clinical and laboratory study
Medicine (Baltimore)
(1964) - et al.
Asymptomatic bacteriuria in schoolgirls. II. Differences in Escherichia coli causing asymptomatic bacteriuria
Acta Paediatr Scand
(1975) - et al.
Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract
Int J Med Microbiol
(2005) - et al.
Neutrophil recruitment and resistance to urinary tract infection
J Infect Dis
(1999) - et al.
Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart
J Exp Med
(2000)
Über neue thermolabile Körperantigene der Colibakterien
Acta Path Microbiol Scand
Escherichia coli serotypes and renal involvement in urinary-tract infection
Lancet
Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection
Lancet
Bacterial attachment and inflammation in the urinary tract
J Infect Dis
Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro
Infect Immun
Selective cytokine production by epithelial cells following exposure to Escherichia coli
Infect Immun
Virulence factors in Escherichia coli urinary tract infection
Clin Microbiol Rev
Internalization of Escherichia coli into human kidney epithelial cells: comparison of fecal and pyelonephritis-associated strains
J Infect Dis
Pathogenicity islands and the evolution of microbes
Annu Rev Microbiol
Virulence factors of uropathogens
Curr Opin Urol
Binding to and killing of human renal epithelial cells by hemolytic P-fimbriated E. coli
Kidney Int
The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48
Proc Natl Acad Sci U S A
Type 1 pilus-mediated bacterial invasion of bladder epithelial cells
EMBO J
Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-κB
Infect Immun
Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism
J Immunol
P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract
Cell Microbiol
Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa
Infect Immun
Selection and evolution of virulence in bacteria: an ecumenical excursion and modest suggestion
Parasitology
Resident colonic Escherichia coli strains frequently display uropathogenic characteristics
J Infect Dis
The natural history of bacteriuria in childhood
Infect Dis Clin North Am
Interleukin-8 receptor deficiency confers susceptibility to acute pyelonephritis
J Infect Dis
Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection
J Immunol
PapG-dependent adherence breaks mucosal inertia and triggers the innate immmune response
J Infect Dis
Cited by (96)
Recurrent urinary tract infections in women: How promising is the use of probiotics?
2017, Indian Journal of Medical MicrobiologyThe Genetic Basis of the Symbiosis Between Photorhabdus and Its Invertebrate Hosts
2014, Advances in Applied MicrobiologyInteractions between LPS moieties and macrophage pattern recognition receptors
2013, Veterinary Immunology and ImmunopathologyQuorum sensing signal molecules cause renal tissue inflammation through local cytokine responses in experimental UTI caused by Pseudomonas aeruginosa
2013, ImmunobiologyCitation Excerpt :On the other hand, all the mice infected with quorum sensing mutant strains yielded negative results confirming no production of AHLs in kidney homogenates (p ≤ 0.0001, Fig. 3). UTI's activate both mucosal and systemic inflammatory responses in which cytokines play a pivotal role (Svanborg et al. 2006). Mucosa of infected urinary tract triggers both pro and anti-inflammatory cytokines produced largely by macrophages and epithelial cells (Agace et al. 1993).